Entering into a clinical supply agreement for a Phase 3 trial is a significant milestone for Koru Medical Systems. It not only validates the company's technology and its application in critical healthcare solutions but also potentially opens up new revenue streams upon successful trial outcomes. The use of the Freedom System in this trial underscores its adaptability and effectiveness in drug delivery, which could lead to increased demand and positive market perception.